Condition: Cystectomy · Bladder Cancer Requiring Cystectomy · Postoperative Infections · Sponsor: Rigshospitalet, Denmark
The aim of this trial is to test whether postoperative antibiotics targeted towards bacteria in the urine can reduce the risk of infection after surgical removal of the bladder (cystectomy) compared to a standardised antibiotic prophylaxis. Participants undergoing cystectomy will be randomly assigned to postoperatively receive (A) a standardised orally administered antibiotic prophylaxis currently given at Rigshospitalet, Copenhagen or (B) a conventional orally administered antibiotic prophylaxis targeting bacteria found in the urine postoperatively. The investigators' hypothesis is that the targeted prophylactic antibiotic strategy will reduce the number of infection-related readmissions within 90 days of surgery compared to the standardised prophylaxis.
This description comes directly from the study's public registry record.
Maja Vejlgaard · +4535456152 · maja.vejlgaard.02@regionh.dk
Always discuss trial participation with your own doctor first.
| Department of Urology, Aalborg University Hospital | Aalborg, Denmark | Not Yet Recruiting |
| Department of Urology, Aarhus University Hospital | Aarhus, Denmark | Not Yet Recruiting |
| Department of Urology, Rigshospitalet | Copenhagen, Denmark | Recruiting |
| Department of Urology, Herlev and Gentofte Hospital | Herlev, Denmark | Not Yet Recruiting |
| Department of Urology, Odense University Hospital | Odense, Denmark | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06709196